Royal Bank Of Canada Agenus Inc Transaction History

Royal Bank Of Canada

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 05, 2024	BUY	$0.53 - $0.93 $5,424 - $9,518	10,235 New	10,235 $5,000
Q1 2024 May 15, 2024	SELL	$0.53 - $0.93 $58,400 - $102,476	-110,190 Reduced 91.5%	10,235 $5,000
Q4 2023 Feb 14, 2024	BUY	$0.63 - $1.14 $40,257 - $72,847	63,901 Added 113.05%	120,425 $99,000
Q3 2023 Nov 14, 2023	BUY	$1.12 - $1.88 $20,142 - $33,809	17,984 Added 46.66%	56,524 $63,000
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $27,954 - $43,531	21,339 Added 124.06%	38,540 $61,000
Q1 2023 May 15, 2023	SELL	$1.45 - $2.95 $33,476 - $68,106	-23,087 Reduced 57.3%	17,201 $26,000
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $74,422 - $119,739	36,843 Added 1069.46%	40,288 $96,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $3,769 - $6,038	1,923 Added 126.35%	3,445 $7,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.64 $15,529 - $31,537	-11,946 Reduced 88.7%	1,522 $3,000
Q1 2022 May 16, 2022	SELL	$2.35 - $3.47 $82,670 - $122,071	-35,179 Reduced 72.31%	13,468 $33,000
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $130,392 - $256,319	44,655 Added 1118.61%	48,647 $157,000
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $19,755 - $26,301	3,967 Added 15868.0%	3,992 $21,000
Q2 2021 Aug 16, 2021	BUY	$2.56 - $5.49 $64 - $137	25 New	25 $0

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.